Patents by Inventor Katherine Durrer

Katherine Durrer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetically modified probiotic for the treatment of phenylketonuria (PKU) disease
    Patent number: 10744168
    Abstract: A GMP adapted to provide the PAL gene for the treatment of PKU when administered orally. The GMP of the present invention may include a probiotic, a PAL gene to be expressed using the probiotic, wherein the PAL gene is functionally attached to a promoter and a ribosome binding site, and may be codon-optimized for expression in a certain host organism. A method of treating the metabolic disease of PKU by oral administration and ingestion of a GMP is also provided.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: August 18, 2020
    Assignee: UNIVERSITY OF NORTH TEXAS
    Inventors: Katherine Durrer, Michael Allen, Ione Hunt von Herbing
  • GENETICALLY MODIFIED PROBIOTIC FOR THE TREATMENT OF PHENYLKETONURIA (PKU) DISEASE
    Publication number: 20180117101
    Abstract: A GMP adapted to provide the PAL gene for the treatment of PKU when administered orally. The GMP of the present invention may include a probiotic, a PAL gene to be expressed using the probiotic, wherein the PAL gene is functionally attached to a promoter and a ribosome binding site, and may be codon-optimized for expression in a certain host organism. A method of treating the metabolic disease of PKU by oral administration and ingestion of a GMP is also provided.
    Type: Application
    Filed: November 1, 2017
    Publication date: May 3, 2018
    Inventors: Katherine Durrer, Michael Allen, Ione Hunt von Herbing